Vertical Transmission

Exposure to ART in utero or early life doesn't appear be harmful

Published in AIDS Weekly, May 26th, 2003

Given concerns about the potential for adverse effects on unborn and newborn children exposed to prophylactic antiretroviral therapy (ART), researchers said they find data from a large study that indicate no serious adverse events in a large study "reassuring."

The findings come from data on uninfected children enrolled in the European Collaborative Study. M.L. Newell and colleagues, University College London, wanted to see if there were any links among ART exposure and subsequent perinatal problems and major adverse health events later in the children's lives.

The median length of follow-up of 2,414 uninfected children was 2.2 (0-15.9) years. Over a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2003-05-26)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry